402 related articles for article (PubMed ID: 8929948)
21. Clinical and molecular characterization of Brazilian families with von Hippel-Lindau disease: a need for delineating genotype-phenotype correlation.
Gomy I; Molfetta GA; de Andrade Barreto E; Ferreira CA; Zanette DL; Casali-da-Rocha JC; Silva WA
Fam Cancer; 2010 Dec; 9(4):635-42. PubMed ID: 20567917
[TBL] [Abstract][Full Text] [Related]
22. Von Hippel-Lindau disease: delayed presentation as a cerebellar haemangioblastoma in an elderly patient.
Shekhar H; Myles L; Lee M
Br J Neurosurg; 2009 Feb; 23(1):97-8. PubMed ID: 19234919
[TBL] [Abstract][Full Text] [Related]
23. Surveillance in von Hippel-Lindau disease (vHL).
Poulsen ML; Budtz-Jørgensen E; Bisgaard ML
Clin Genet; 2010 Jan; 77(1):49-59. PubMed ID: 19863552
[TBL] [Abstract][Full Text] [Related]
24. Survival and causes of death in patients with von Hippel-Lindau disease.
Binderup ML; Jensen AM; Budtz-Jørgensen E; Bisgaard ML
J Med Genet; 2017 Jan; 54(1):11-18. PubMed ID: 27539272
[TBL] [Abstract][Full Text] [Related]
25. Clinical characteristics of ocular angiomatosis in von Hippel-Lindau disease and correlation with germline mutation.
Webster AR; Maher ER; Moore AT
Arch Ophthalmol; 1999 Mar; 117(3):371-8. PubMed ID: 10088816
[TBL] [Abstract][Full Text] [Related]
26. Genetic study of a large Chinese kindred with von Hippel-Lindau disease.
Huang YR; Zhang J; Wang JD; Fan XD
Chin Med J (Engl); 2004 Apr; 117(4):552-7. PubMed ID: 15109448
[TBL] [Abstract][Full Text] [Related]
27. Repurposing propranolol as a drug for the treatment of retinal haemangioblastomas in von Hippel-Lindau disease.
Albiñana V; Escribano RMJ; Soler I; Padial LR; Recio-Poveda L; Villar Gómez de Las Heras K; Botella LM
Orphanet J Rare Dis; 2017 Jun; 12(1):122. PubMed ID: 28662711
[TBL] [Abstract][Full Text] [Related]
28. VHL mutation analysis in patients with isolated central nervous system haemangioblastoma.
Woodward ER; Wall K; Forsyth J; Macdonald F; Maher ER
Brain; 2007 Mar; 130(Pt 3):836-42. PubMed ID: 17264095
[TBL] [Abstract][Full Text] [Related]
29. Phenotypic expression in von Hippel-Lindau disease: correlations with germline VHL gene mutations.
Maher ER; Webster AR; Richards FM; Green JS; Crossey PA; Payne SJ; Moore AT
J Med Genet; 1996 Apr; 33(4):328-32. PubMed ID: 8730290
[TBL] [Abstract][Full Text] [Related]
30. Von Hippel-Lindau disease germline mutations in Mexican patients with cerebellar hemangioblastoma.
Rasmussen A; Nava-Salazar S; Yescas P; Alonso E; Revuelta R; Ortiz I; Canizales-Quinteros S; Tusié-Luna MT; López-López M
J Neurosurg; 2006 Mar; 104(3):389-94. PubMed ID: 16572651
[TBL] [Abstract][Full Text] [Related]
31. [Hippel-Lindau disease].
Krzystolik K; Cybulski C; Lubiński J
Neurol Neurochir Pol; 1998; 32(5):1119-33. PubMed ID: 10463227
[TBL] [Abstract][Full Text] [Related]
32. VHL disease.
Barontini M; Dahia PL
Best Pract Res Clin Endocrinol Metab; 2010 Jun; 24(3):401-13. PubMed ID: 20833332
[TBL] [Abstract][Full Text] [Related]
33. Incidence of von Hippel-Lindau disease in hemangioblastoma patients: the University of Tokyo Hospital experience from 1954-1998.
Sora S; Ueki K; Saito N; Kawahara N; Shitara N; Kirino T
Acta Neurochir (Wien); 2001 Sep; 143(9):893-6. PubMed ID: 11685621
[TBL] [Abstract][Full Text] [Related]
34. Molecular characterization and ophthalmic investigation of a large family with type 2A Von Hippel-Lindau Disease.
Allen RC; Webster AR; Sui R; Brown J; Taylor CM; Stone EM
Arch Ophthalmol; 2001 Nov; 119(11):1659-65. PubMed ID: 11709017
[TBL] [Abstract][Full Text] [Related]
35. [Genetic analysis of a family with Von Hippel-Lindau syndrome].
Lafuente-Sanchis A; Cuevas JM; Alemany P; Cremades A; Zúñiga Á
Rev Esp Patol; 2017; 50(1):64-67. PubMed ID: 29179968
[TBL] [Abstract][Full Text] [Related]
36. Genotype-phenotype correlation in von Hippel-Lindau disease.
Reich M; Jaegle S; Neumann-Haefelin E; Klingler JH; Evers C; Daniel M; Bucher F; Ludwig F; Nuessle S; Kopp J; Boehringer D; Reinhard T; Lagrèze WA; Lange C; Agostini H; Lang SJ
Acta Ophthalmol; 2021 Dec; 99(8):e1492-e1500. PubMed ID: 33720516
[TBL] [Abstract][Full Text] [Related]
37. A clinical and molecular genetic analysis of solitary ocular angioma.
Webster AR; Maher ER; Bird AC; Gregor ZJ; Moore AT
Ophthalmology; 1999 Mar; 106(3):623-9. PubMed ID: 10080225
[TBL] [Abstract][Full Text] [Related]
38. Pediatric endocrine screening for von Hippel-Lindau disease: benefits and the challenge of compliance.
Prasad R; Johnston LB; Savage MO; Martin L; Perry LA; Storr HL
J Endocrinol Invest; 2011 Apr; 34(4):296-9. PubMed ID: 20585202
[TBL] [Abstract][Full Text] [Related]
39. von Hippel-Lindau syndrome.
Chou A; Toon C; Pickett J; Gill AJ
Front Horm Res; 2013; 41():30-49. PubMed ID: 23652669
[TBL] [Abstract][Full Text] [Related]
40. [Does hemangioblastoma exist outside von Hippel-Lindau disease?].
Richard S; Beigelman C; Gerber S; Van Effenterre R; Gaudric A; Sahel M; Binaghi M; De Kersaint-Gilly A; Houtteville JP; Brunon JP
Neurochirurgie; 1994; 40(3):145-54. PubMed ID: 7723921
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
